{"transactions":[{"id":324077,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2025-03-12T22:10:09.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":1952,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":9875,"derivative":{"underlying":"Common Stock","underlying_shares":1952},"source":{"system":"sec-edgar","filing":"0001127602-25-009265","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009265/form4.xml","form_type":"4"}},{"id":324076,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2025-03-12T22:10:09.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":624,"price":117.21,"value":73139.04,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan."}],"balance_after":39453,"source":{"system":"sec-edgar","filing":"0001127602-25-009265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009265/form4.xml","form_type":"4"}},{"id":324075,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2025-03-12T22:10:09.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":1952,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":40077,"source":{"system":"sec-edgar","filing":"0001127602-25-009265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009265/form4.xml","form_type":"4"}},{"id":326450,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2025-02-06T21:24:50.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting person on March 10, 2024. Such tranches of shares were subject to both performance-vesting and\nservice-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of the performance goal attainment by the Compensation and Talent Committee of the\nIssuer's Board of Directors. However, the shares will not be issued to the Reporting person until the requisite continuing service requirements are met."}],"balance_after":37787,"source":{"system":"sec-edgar","filing":"0001127602-25-003401","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225003401/form4.xml","form_type":"4"}},{"id":328334,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2024-12-16T21:22:28.000Z","date":"2024-12-13","kind":"exercise","planned":false,"acquired":false,"shares":157,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":11827,"derivative":{"underlying":"Common Stock","underlying_shares":157},"source":{"system":"sec-edgar","filing":"0001127602-24-029490","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029490/form4.xml","form_type":"4"}},{"id":328333,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2024-12-16T21:22:28.000Z","date":"2023-12-13","kind":"exercise","planned":false,"acquired":false,"shares":117,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":11984,"derivative":{"underlying":"Common Stock","underlying_shares":117},"source":{"system":"sec-edgar","filing":"0001127602-24-029490","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029490/form4.xml","form_type":"4"}},{"id":328332,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2024-12-16T21:22:28.000Z","date":"2023-12-13","kind":"exercise","planned":false,"acquired":false,"shares":181,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a three year vesting schedule.  33.33% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a three year vesting schedule.  33.33% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":12101,"derivative":{"underlying":"Common Stock","underlying_shares":181},"source":{"system":"sec-edgar","filing":"0001127602-24-029490","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029490/form4.xml","form_type":"4"}},{"id":328331,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2024-12-16T21:22:28.000Z","date":"2024-12-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":157,"price":91.855,"value":14421.235,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Mandatory tax withholding on vesting of restricted stock units due to retirement eligibility."}],"balance_after":37078,"source":{"system":"sec-edgar","filing":"0001127602-24-029490","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029490/form4.xml","form_type":"4"}},{"id":328330,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2024-12-16T21:22:28.000Z","date":"2023-12-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":298,"price":83.09,"value":24760.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Mandatory tax withholding on vesting of restricted stock units due to retirement eligibility."}],"balance_after":37235,"source":{"system":"sec-edgar","filing":"0001127602-24-029490","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029490/form4.xml","form_type":"4"}},{"id":328329,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2024-12-16T21:22:28.000Z","date":"2024-12-13","kind":"exercise","planned":false,"acquired":true,"shares":157,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":37533,"source":{"system":"sec-edgar","filing":"0001127602-24-029490","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029490/form4.xml","form_type":"4"}},{"id":328328,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2024-12-16T21:22:28.000Z","date":"2023-12-13","kind":"exercise","planned":false,"acquired":true,"shares":117,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":37376,"source":{"system":"sec-edgar","filing":"0001127602-24-029490","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029490/form4.xml","form_type":"4"}},{"id":328327,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2024-12-16T21:22:28.000Z","date":"2023-12-13","kind":"exercise","planned":false,"acquired":true,"shares":181,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":37259,"source":{"system":"sec-edgar","filing":"0001127602-24-029490","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029490/form4.xml","form_type":"4"}},{"id":328467,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2024-12-12T00:48:18.000Z","date":"2024-12-10","kind":"exercise","planned":false,"acquired":false,"shares":901,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":12282,"derivative":{"underlying":"Common Stock","underlying_shares":901},"source":{"system":"sec-edgar","filing":"0001127602-24-029178","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029178/form4.xml","form_type":"4"}},{"id":328466,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2024-12-12T00:48:18.000Z","date":"2024-12-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":408,"price":92.34,"value":37674.72,"ownership":{"direct":true},"balance_after":37078,"source":{"system":"sec-edgar","filing":"0001127602-24-029178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029178/form4.xml","form_type":"4"}},{"id":328465,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2024-12-12T00:48:18.000Z","date":"2024-12-10","kind":"exercise","planned":false,"acquired":true,"shares":901,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":37486,"source":{"system":"sec-edgar","filing":"0001127602-24-029178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224029178/form4.xml","form_type":"4"}},{"id":330823,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2024-09-11T23:38:13.000Z","date":"2024-09-10","kind":"exercise","planned":false,"acquired":false,"shares":901,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":13183,"derivative":{"underlying":"Common Stock","underlying_shares":901},"source":{"system":"sec-edgar","filing":"0001127602-24-023823","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224023823/form4.xml","form_type":"4"}},{"id":330822,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2024-09-11T23:38:13.000Z","date":"2024-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":292,"price":81.44,"value":23780.48,"ownership":{"direct":true},"balance_after":36585,"source":{"system":"sec-edgar","filing":"0001127602-24-023823","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224023823/form4.xml","form_type":"4"}},{"id":330821,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2024-09-11T23:38:13.000Z","date":"2024-09-10","kind":"exercise","planned":false,"acquired":true,"shares":901,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":36877,"source":{"system":"sec-edgar","filing":"0001127602-24-023823","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224023823/form4.xml","form_type":"4"}},{"id":331439,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2024-08-12T20:22:36.000Z","date":"2024-08-10","kind":"exercise","planned":false,"acquired":false,"shares":3678,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a three year vesting schedule.  33.33% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a three year vesting schedule.  33.33% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":14084,"derivative":{"underlying":"Common Stock","underlying_shares":3678},"source":{"system":"sec-edgar","filing":"0001127602-24-022009","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224022009/form4.xml","form_type":"4"}},{"id":331438,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2024-08-12T20:22:36.000Z","date":"2024-08-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":980,"price":73.66,"value":72186.8,"ownership":{"direct":true},"balance_after":35976,"source":{"system":"sec-edgar","filing":"0001127602-24-022009","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224022009/form4.xml","form_type":"4"}},{"id":331437,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2024-08-12T20:22:36.000Z","date":"2024-08-10","kind":"exercise","planned":false,"acquired":true,"shares":3678,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":36956,"source":{"system":"sec-edgar","filing":"0001127602-24-022009","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224022009/form4.xml","form_type":"4"}},{"id":332905,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2024-06-11T23:23:09.000Z","date":"2024-06-10","kind":"exercise","planned":false,"acquired":false,"shares":901,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":17762,"derivative":{"underlying":"Common Stock","underlying_shares":901},"source":{"system":"sec-edgar","filing":"0001127602-24-018419","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224018419/form4.xml","form_type":"4"}},{"id":332904,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2024-06-11T23:23:09.000Z","date":"2024-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":255,"price":65.25,"value":16638.75,"ownership":{"direct":true},"balance_after":33278,"source":{"system":"sec-edgar","filing":"0001127602-24-018419","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224018419/form4.xml","form_type":"4"}},{"id":332903,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2024-06-11T23:23:09.000Z","date":"2024-06-10","kind":"exercise","planned":false,"acquired":true,"shares":901,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":33533,"source":{"system":"sec-edgar","filing":"0001127602-24-018419","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224018419/form4.xml","form_type":"4"}},{"id":337534,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2024-03-12T19:57:35.000Z","date":"2024-03-10","kind":"grant","planned":false,"acquired":true,"shares":4825,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":18663,"derivative":{"underlying":"Common Stock","underlying_shares":4825},"source":{"system":"sec-edgar","filing":"0001127602-24-009708","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009708/form4.xml","form_type":"4"}},{"id":337533,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-03-12T19:57:35.000Z","date":"2024-03-10","kind":"grant","planned":false,"acquired":true,"shares":13660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option have a four year vesting schedule.  25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":13660,"derivative":{"exercise_price":75.12,"expiration_date":"2034-03-10","underlying":"Common Stock","underlying_shares":13660},"source":{"system":"sec-edgar","filing":"0001127602-24-009708","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009708/form4.xml","form_type":"4"}},{"id":337532,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2024-03-12T19:57:35.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":false,"shares":1934,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":13838,"derivative":{"underlying":"Common Stock","underlying_shares":1934},"source":{"system":"sec-edgar","filing":"0001127602-24-009708","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009708/form4.xml","form_type":"4"}},{"id":337531,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2024-03-12T19:57:35.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":false,"shares":748,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":15772,"derivative":{"underlying":"Common Stock","underlying_shares":748},"source":{"system":"sec-edgar","filing":"0001127602-24-009708","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009708/form4.xml","form_type":"4"}},{"id":337530,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2024-03-12T19:57:35.000Z","date":"2024-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":790,"price":75.12,"value":59344.8,"ownership":{"direct":true},"balance_after":32632,"source":{"system":"sec-edgar","filing":"0001127602-24-009708","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009708/form4.xml","form_type":"4"}},{"id":337529,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2024-03-12T19:57:35.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":true,"shares":1934,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":33422,"source":{"system":"sec-edgar","filing":"0001127602-24-009708","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009708/form4.xml","form_type":"4"}},{"id":337528,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2024-03-12T19:57:35.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":true,"shares":748,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan."}],"balance_after":31488,"source":{"system":"sec-edgar","filing":"0001127602-24-009708","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224009708/form4.xml","form_type":"4"}},{"id":343789,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2023-12-12T00:08:00.000Z","date":"2023-12-10","kind":"exercise","planned":false,"acquired":false,"shares":518,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":16520,"derivative":{"underlying":"Common Stock","underlying_shares":518},"source":{"system":"sec-edgar","filing":"0001127602-23-029245","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223029245/form4.xml","form_type":"4"}},{"id":343788,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2023-12-12T00:08:00.000Z","date":"2023-12-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":222,"price":79.02,"value":17542.44,"ownership":{"direct":true},"balance_after":30420,"source":{"system":"sec-edgar","filing":"0001127602-23-029245","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223029245/form4.xml","form_type":"4"}},{"id":343787,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2023-12-12T00:08:00.000Z","date":"2023-12-10","kind":"exercise","planned":false,"acquired":true,"shares":518,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":30642,"source":{"system":"sec-edgar","filing":"0001127602-23-029245","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223029245/form4.xml","form_type":"4"}},{"id":345908,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2023-09-12T00:37:41.000Z","date":"2023-09-10","kind":"exercise","planned":false,"acquired":false,"shares":519,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":17038,"derivative":{"underlying":"Common Stock","underlying_shares":519},"source":{"system":"sec-edgar","filing":"0001127602-23-023981","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223023981/form4.xml","form_type":"4"}},{"id":345907,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2023-09-12T00:37:41.000Z","date":"2023-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":149,"price":76,"value":11324.0,"ownership":{"direct":true},"balance_after":30124,"source":{"system":"sec-edgar","filing":"0001127602-23-023981","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223023981/form4.xml","form_type":"4"}},{"id":345906,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2023-09-12T00:37:41.000Z","date":"2023-09-10","kind":"exercise","planned":false,"acquired":true,"shares":519,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":30273,"source":{"system":"sec-edgar","filing":"0001127602-23-023981","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223023981/form4.xml","form_type":"4"}},{"id":346658,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2023-08-11T20:36:30.000Z","date":"2023-08-10","kind":"exercise","planned":false,"acquired":false,"shares":4484,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a three year vesting schedule.  33.33% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a three year vesting schedule.  33.33% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":17557,"derivative":{"underlying":"Common Stock","underlying_shares":4484},"source":{"system":"sec-edgar","filing":"0001127602-23-022375","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223022375/form4.xml","form_type":"4"}},{"id":346657,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2023-08-11T20:36:30.000Z","date":"2023-08-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1306,"price":80,"value":104480.0,"ownership":{"direct":true},"balance_after":29754,"source":{"system":"sec-edgar","filing":"0001127602-23-022375","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223022375/form4.xml","form_type":"4"}},{"id":346656,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2023-08-11T20:36:30.000Z","date":"2023-08-10","kind":"exercise","planned":false,"acquired":true,"shares":4484,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":31060,"source":{"system":"sec-edgar","filing":"0001127602-23-022375","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223022375/form4.xml","form_type":"4"}},{"id":348341,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2023-06-12T20:50:04.000Z","date":"2023-06-10","kind":"exercise","planned":false,"acquired":false,"shares":517,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":22041,"derivative":{"underlying":"Common Stock","underlying_shares":517},"source":{"system":"sec-edgar","filing":"0001127602-23-018592","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223018592/form4.xml","form_type":"4"}},{"id":348340,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2023-06-12T20:50:04.000Z","date":"2023-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":153,"price":78.12,"value":11952.36,"ownership":{"direct":true},"balance_after":26576,"source":{"system":"sec-edgar","filing":"0001127602-23-018592","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223018592/form4.xml","form_type":"4"}},{"id":348339,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2023-06-12T20:50:04.000Z","date":"2023-06-10","kind":"exercise","planned":false,"acquired":true,"shares":517,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":26729,"source":{"system":"sec-edgar","filing":"0001127602-23-018592","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223018592/form4.xml","form_type":"4"}},{"id":351514,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2023-03-14T01:04:37.000Z","date":"2023-03-10","kind":"grant","acquired":true,"shares":10405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option have a four year vesting schedule.  25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":10405,"derivative":{"exercise_price":79.5,"expiration_date":"2033-03-10","underlying":"Common Stock","underlying_shares":10405},"source":{"system":"sec-edgar","filing":"0001127602-23-009984","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223009984/form4.xml","form_type":"4"}},{"id":351513,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2023-03-14T01:04:37.000Z","date":"2023-03-10","kind":"grant","acquired":true,"shares":6130,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":22558,"derivative":{"underlying":"Common Stock","underlying_shares":6130},"source":{"system":"sec-edgar","filing":"0001127602-23-009984","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223009984/form4.xml","form_type":"4"}},{"id":351512,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2023-03-14T01:04:37.000Z","date":"2023-03-10","kind":"exercise","acquired":false,"shares":1320,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":16428,"derivative":{"underlying":"Common Stock","underlying_shares":1320},"source":{"system":"sec-edgar","filing":"0001127602-23-009984","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223009984/form4.xml","form_type":"4"}},{"id":351511,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2023-03-14T01:04:37.000Z","date":"2023-03-10","kind":"exercise","acquired":false,"shares":1601,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":17748,"derivative":{"underlying":"Common Stock","underlying_shares":1601},"source":{"system":"sec-edgar","filing":"0001127602-23-009984","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223009984/form4.xml","form_type":"4"}},{"id":351510,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2023-03-14T01:04:37.000Z","date":"2023-03-10","kind":"tax_withholding","acquired":false,"shares":801,"price":79.5,"value":63679.5,"ownership":{"direct":true},"balance_after":26212,"source":{"system":"sec-edgar","filing":"0001127602-23-009984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223009984/form4.xml","form_type":"4"}},{"id":351509,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2023-03-14T01:04:37.000Z","date":"2023-03-10","kind":"exercise","acquired":true,"shares":1320,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":27013,"source":{"system":"sec-edgar","filing":"0001127602-23-009984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223009984/form4.xml","form_type":"4"}},{"id":351508,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":15122,"kind":"person","name":"Patterson Sandra","position":1,"cik":"0001968906","reported_name":"Patterson Sandra","relationship":{"officer":true,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2023-03-14T01:04:37.000Z","date":"2023-03-10","kind":"exercise","acquired":true,"shares":1601,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":25693,"source":{"system":"sec-edgar","filing":"0001127602-23-009984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223009984/form4.xml","form_type":"4"}}]}